Evidence map›Paper›PMID 40742372›Full record

ArticleMicrobiology spectrum2025

Virulence signature of the endemic vancomycin-resistant

Ingrid Maria Cecilia Rubin, Kasper Thystrup Karstensen, Mikkel Lindegaard, Kristin Hegstad, Ana R Freitas, Anette M Hammerum, Louise Roer

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Genomic epidemiology ofJournal of clinical microbiology · 2026
    Observational
  5. New microbes and new infections · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ingrid Maria Cecilia RubinDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.ORCID 0000-0002-6158-2927
Kasper Thystrup KarstensenDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.ORCID 0000-0002-5009-0476
Mikkel LindegaardDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Kristin HegstadResearch Group for Host-Microbe Interactions, Department of Medical Biology, Faculty of Health Sciences, UiT, The Arctic University of Norway, Tromsø, Norway.ORCID 0000-0002-1314-0497
Ana R FreitasUCIBIO, Unidade de Ciências Biomoleculares Aplicadas, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal.ORCID 0000-0002-7326-4133
Anette M HammerumDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.ORCID 0000-0001-9471-1601
Louise RoerDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.ORCID 0000-0001-6892-913X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since 2012, Denmark has seen a significant rise in vancomycin-resistant

Indexed as

Drug Resistance, BacterialEnterococcus faeciumGram-Positive Bacterial InfectionsVancomycinDenmarkHumansPhylogenyVirulenceVancomycinEnterococcus faeciumvirulenceFindervirulence markersVRE

Identifiers

PMID40742372
PMCPMC12403981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.